These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 12083631)
1. Hormone receptors in breast cancer: racial differences in distribution and survival. Joslyn SA Breast Cancer Res Treat; 2002 May; 73(1):45-59. PubMed ID: 12083631 [TBL] [Abstract][Full Text] [Related]
2. Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data. Schinkel JK; Zahm SH; Jatoi I; McGlynn KA; Gallagher C; Schairer C; Shriver CD; Zhu K Cancer Causes Control; 2014 Aug; 25(8):959-68. PubMed ID: 24839049 [TBL] [Abstract][Full Text] [Related]
3. Racial differences in breast carcinoma survival. Joslyn SA; West MM Cancer; 2000 Jan; 88(1):114-23. PubMed ID: 10618613 [TBL] [Abstract][Full Text] [Related]
4. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma. Grann VR; Troxel AB; Zojwalla NJ; Jacobson JS; Hershman D; Neugut AI Cancer; 2005 Jun; 103(11):2241-51. PubMed ID: 15844176 [TBL] [Abstract][Full Text] [Related]
5. Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. Li CI; Daling JR; Malone KE J Clin Oncol; 2003 Jan; 21(1):28-34. PubMed ID: 12506166 [TBL] [Abstract][Full Text] [Related]
6. Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women. Cui Y; Deming-Halverson SL; Shrubsole MJ; Beeghly-Fadiel A; Fair AM; Sanderson M; Shu XO; Kelley MC; Zheng W Clin Breast Cancer; 2014 Dec; 14(6):417-25. PubMed ID: 24970715 [TBL] [Abstract][Full Text] [Related]
7. Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources. Akinyemiju T; Moore JX; Ojesina AI; Waterbor JW; Altekruse SF Breast Cancer Res Treat; 2016 Jun; 157(3):575-86. PubMed ID: 27255533 [TBL] [Abstract][Full Text] [Related]
8. Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. Kurian AW; Fish K; Shema SJ; Clarke CA Breast Cancer Res; 2010; 12(6):R99. PubMed ID: 21092082 [TBL] [Abstract][Full Text] [Related]
9. Disparities and survival among breast cancer patients. Field TS; Buist DS; Doubeni C; Enger S; Fouayzi H; Hart G; Korner EJ; Lamerato L; Bachman DJ; Ellis J; Herrinton L; Hornbrook MC; Krajenta R; Liu L; Yao J J Natl Cancer Inst Monogr; 2005; (35):88-95. PubMed ID: 16287892 [TBL] [Abstract][Full Text] [Related]
10. Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype. Hausauer AK; Keegan TH; Chang ET; Clarke CA Breast Cancer Res; 2007; 9(6):R90. PubMed ID: 18162138 [TBL] [Abstract][Full Text] [Related]
11. Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. Chu KC; Anderson WF; Fritz A; Ries LA; Brawley OW Cancer; 2001 Jul; 92(1):37-45. PubMed ID: 11443607 [TBL] [Abstract][Full Text] [Related]
12. Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series. McCormack VA; Joffe M; van den Berg E; Broeze N; Silva Idos S; Romieu I; Jacobson JS; Neugut AI; Schüz J; Cubasch H Breast Cancer Res; 2013; 15(5):R84. PubMed ID: 24041225 [TBL] [Abstract][Full Text] [Related]
13. Prognostic features of breast cancer differ between women in the Democratic Republic of Congo and Belgium. Luyeye Mvila G; Batalansi D; Praet M; Marchal G; Laenen A; Christiaens MR; Brouckaert O; Ali-Risasi C; Neven P; Van Ongeval C Breast; 2015 Oct; 24(5):642-8. PubMed ID: 26279132 [TBL] [Abstract][Full Text] [Related]
14. Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities. Rauscher GH; Silva A; Pauls H; Frasor J; Bonini MG; Hoskins K Breast Cancer Res Treat; 2017 Jun; 163(2):321-330. PubMed ID: 28251385 [TBL] [Abstract][Full Text] [Related]
15. Breast cancer incidence in black and white women stratified by estrogen and progesterone receptor statuses. Gleason MX; Mdzinarishvili T; Sherman S PLoS One; 2012; 7(11):e49359. PubMed ID: 23166647 [TBL] [Abstract][Full Text] [Related]
16. Primary tumor size, not race, determines outcomes in women with hormone-responsive breast cancer. Chagpar AB; Crutcher CR; Cornwell LB; McMasters KM Surgery; 2011 Oct; 150(4):796-801. PubMed ID: 22000193 [TBL] [Abstract][Full Text] [Related]
17. The greater impact of menopause on ER- than ER+ breast cancer incidence: a possible explanation (United States). Tarone RE; Chu KC Cancer Causes Control; 2002 Feb; 13(1):7-14. PubMed ID: 11899120 [TBL] [Abstract][Full Text] [Related]
18. Triple-negative breast carcinoma in African American and Caucasian women: clinicopathology, immunomarkers, and outcome. Sullivan HC; Oprea-Ilies G; Adams AL; Page AJ; Kim S; Wang J; Cohen C Appl Immunohistochem Mol Morphol; 2014 Jan; 22(1):17-23. PubMed ID: 23455177 [TBL] [Abstract][Full Text] [Related]
19. Within-stage racial differences in tumor size and number of positive lymph nodes in women with breast cancer. McBride R; Hershman D; Tsai WY; Jacobson JS; Grann V; Neugut AI Cancer; 2007 Sep; 110(6):1201-8. PubMed ID: 17701948 [TBL] [Abstract][Full Text] [Related]